Aducanumab: How the new and controversial Alzheimer’s drug works – Kleine Zeitung

  1. Aducanumab: How the new and controversial Alzheimer’s drug worksSmall newspaper
  2. Controversial Alzheimer’s drug approved in the USaponet.de
  3. Alzheimer’s drug: Numerous companies want to benefitNeue Zürcher Zeitung – NZZ
  4. Drugs against Alzheimer’s disease: research is becoming a billion-dollar graveBusiness Insider Germany
  5. Podcast: Biogen achieves breakthrough in the fight against Alzheimer’s – FDA sets milestone in approvalTHE SHAREHOLDER TV
  6. See “More on Topic” in Google News
See also  Tiroler Plansee Group turns 100

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.